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The purposes of this study were to determine the differences in spirometric measures obtained
from patients with endoscopically-documented paradoxical vocal fold motion (PVFM) and to
compare them to a group of normal subjects without endoscopically-documented paradoxical
vocal fold motion during non-provocative breathing and following speech. Thirty eight subjects
with documented paradoxical vocal fold motion using transnasal flexible laryngoscopy (TFL)
and no history of asthma and 21 normal subjects with documented normal breathing patterns
and normal findings on endoscopy underwent flow-volume loop studies. Endoscopic judgments
of vocal fold motion from three breathing conditions were made by two observers. The results
of the endoscopic judgments indicate that paradoxical motion occurs whether breathing
through the nose or mouth in the PVFM subjects, mainly after speaking and inhalation. In addi-
tion, the spirometry results indicated that the inspiratory measure of FIVC%, FVC% and FIV0.5/
FIVC were significantly lower in the PVFM group compared to the normal subjects. The data
supports the hypothesis that in patients with PVFM, inspiratory spirometric values play a role
in identifying patients with PVFM. The finding of vocal fold closure following a speech utter-
ance in the majority of the PVFM subjects but not in the normal control group warrants further
investigation.
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Paradoxical vocal fold movement (PVFM) is a condition
characterized by upper airway obstruction secondary to the
paradoxical complete or partial adduction of the vocal folds,
occurring primarily on inhalation, and occasionally during
exhalation. PVFM is the current term used by otolaryngolo-
gists and speech-language pathologists while vocal cord
dysfunction (VCD) is the term used primarily by pulmonolo-
gists and allergists. Throughout the allergy, asthma, otolar-
yngology and speech pathology literature, these terms are
used interchangeably. The term PVFM will be used consis-
tently in this study. .Diagnosis of PVFM is based on case
history, pulmonary function testing and the visualization of
the abnormal (paradoxical) movement of the vocal folds
during transnasal flexible laryngoscopic (TFL) examination.
This movement may be seen while the patient is performing
an exercise task such as riding a bicycle or it may occur
spontaneously during restful breathing.1
Spirometry has been reported as an additional investi-
gational tool in the diagnosis of PVFM. The flow-volume
loop pattern in PVFM is characterized by flattening of
truncation of the inspiratory limb, compared to a U-shaped
pattern in normal subjects.2 Abnormal expiratory measures
and concomitant diagnosis of asthma in patients with PVFM
is variable. An incidence of 15%e50% of PFVM concomitant
with asthma is described in the literature.3 Although the
majority of the patients with PVFM are known to have
normal pulmonary function, treatment of patients with
PVFM (misdiagnosed as asthma) often begins with pharma-
cological management of typical pulmonary symptoms, and
in those cases, the results are often unsuccessful.
The flow-volume loop is uniquely helpful in the evaluation
of upper airway obstruction in that the site (extra thoracic or
intra thoracic), thenature (variableorfixed),andtheseverity
of obstruction can be predicted by the configuration of this
loop. The flow-volume loop can assist in accurate differential
diagnosis of PVFM versus other respiratory complaints.
Vertigan et al.4 found that those people with a definite
diagnosis of PVFM tended to have normal expiratory phases,
but attenuation in the inspiratory phase, and those diagnosed
with asthma, presented in an opposite manner.
Recently, it has been suggested that the diagnosis of
PVFM should include both laryngoscopy and pulmonary
function testing, since the sensitivity of the flow-volume
loop may be very low.5 Studies have, in fact, reported
a range of incidence of 23%e100% showing an abnormal
inspiratory loop in patients diagnosed PVFM.6 In PVFM
subjects with abnormal spirometric measures, earlier
findings by Morris and colleagues report a decrease in
forced expiratory volume at 1 s/forced vital capacity
(FEV1/FVC) compared to normal subjects.2 They, along
with other investigators, also report a significant elevation
in the ratio of the mid-vital capacity of the expiratory air
flow to the mid-vital capacity inspiratory capacity of
inspiratory air flow (FEF50/FIF50)
7,8 Moreover, other studies
have reported that abnormally large FEF50/FIF50 ratios may
be present in some but not all patients with PVFM.3,9 Others
have shown that decreased inspiratory flow is the ventila-
tory characteristic of extra thoracic obstruction and results
in higher FEV0.5/FIV0.5.10e12Only cursory observations of endoscopic examinations
to identify the presence of paradoxical motion of the
vocal folds have been reported in the groups that have
been investigated with spirometry and compared to
control groups. The purposes of this study were to
determine the differences in spirometric measures ob-
tained from patients with endoscopically-documented
PVFM and to compare them to a group of normal
subjects without endoscopically-documented paradoxical
vocal fold motion during non-provocative breathing and
following speech.
Materials and methods
Subjects
The Columbia University Internal Review Board approved
this study. The subjects of this study included 38 patients
diagnosed with PVFM based upon the transnasal flexible
laryngoscopic (TFL) examination, case history, and symp-
tomatic complaints, such as shortness of breath, coughing
and throat clearing. They were selected based on a retro-
spective medical chart review of the patients seen at the
Voice and Swallowing Center at Columbia University
Medical Center between September, 2006 and July 2008. All
subjects were adults between the ages of 23e70 years.
Subjects were excluded if they were over 70 years of age,
had concomitant active diseases of asthma or chronic
obstructive pulmonary disease (COPD) or were being
medicated for asthma, chronic obstructive pulmonary
disease (COPD), diabetes mellitus and neurological disor-
ders such as Parkinson’s, cerebral vascular accident or
a progressive neurological conditions or with a more than 20
pack/year history of cigarette smoking. No subjects were
currently smoking. Patients with a forced vital capacity
lower than 75% were also excluded.
A group of 21 healthy non-smoking individuals was
selected to compose the control group. They were
recruited from individuals visiting the clinic with other
patients, and from families and friends of the investigators.
Data for both groups of subjects was collected in the time
period between September 2006 and July 2008.
Procedure
Following a thorough case history that included inquiring
about shortness of breath, coughing, dysphonia, dysphagia
and other symptoms, the patients and subjects underwent
(TFL). Once the individual was comfortable with the
endoscope in place, he/she was asked to breathe through
his/her nose for 20e30 s followed by breathing through his/
her mouth for 20e30 s. The patient was then asked to say
the sound/i/and to repeat a sentence “We see green
trees.” If there was greater than 50% vocal fold adduction
during or after any of the tasks, the subject was considered
to be in the PVFM group. The data was stored for later
judgment by two individuals familiar with endoscopic views
of the vocal folds. In all cases, during the examination, the
subjects were not coughing nor were they experiencing
acute symptoms of dyspnea.
Table 1 Number of patients, gender, symptoms and
laryngeal signs.
PVFM Group
PVFM group n %
Male 13 34.2
Female 25 65.8
Symptoms
Cough 27 71
Throat clearing 20 52.6
Dyspnea 15 39.4
Dysphonia 13 34.2
Dysphagia 8 21
Choking 6 15.7
Laryngospasm 5 13.1
Laryngeal Signs
Larynx posterior edema 38 100
Vocal fold paresis 7 18.4
Vocal fold atrophy 4 10.5
Granuloma 4 10.5
False vocal fold adduction 2 5.2
Muscle tension dysphonia 1 2.6
Normal controls:
Male 10 47.6
Female 11 52.4
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standard flow-volume loop spirometry using a calibrated
hand held spirometer (Koko). A nose clip was placed over
the nose. Subjects were then instructed to “put the
spirometer tube in the mouth, take a deep breath, blow it
out as fast and as hard as possible and then take a deep
breath in again.” This was done twice and the best
performance was submitted for analysis. Data were stored
on an IBM computer using standard software.
Analysis
The TFL exams were reviewed by two speech-language
pathologists with experience in viewing TFL examinations.
Using a “yes/no decision scheme, the judges rated the
presence and the consistency of more than 50% of vocal
fold closure during inhalation, during exhalation and after
speaking. Inter-judge reliability was obtained. Presence
indicated that greater than 50% adduction was seen at least
during part of the exam sequence (breathing or speaking).
Consistency indicated that adduction was seen consistently
during the breathing/speaking sequences.
Results
Thirty eight patients, 13 males and 25 females, with
endoscopic evidence of PVFM whose most common
complaints were chronic cough, throat clearing and short-
ness of breath were included in this analysis. The mean age
of the PVFM group was 54.5 years with a range of 23e70
years and a standard deviation of 11.7 years. A group of 21
normal subjects with no endoscopic evidence of PVFM and
no complaint of shortness of breath or chronic cough acted
as the controls (10 males and 11 females). The mean age of
the control group was 50.5 years, with a range of 27e69
years and a standard deviation of 11.3 years. No statistical
difference was observed between ages of the males and
females, therefore the two groups were combined for
statistical analysis. Table 1 provides a detailed breakdown
of participant’s demographics showing the number of
patients, gender, most common symptoms and laryngeal
signs.
Table 2 shows the inter-judge reliability of the percep-
tual analysis of the TFL examinations of the PVFM group.
According to the data, the judges were reliable in their
judgments of adduction of the vocal folds in all situations
examined. The results indicate that the adduction of the
vocal folds after speaking was the most common abnor-
mality (present in 100% of the patients with a consistency
over then 78.9%). The abnormal movement of the vocal
folds during inhalation was observed in more than 86% of
the patients with a consistency of 76.3%. During exhalation
over 65.8% of patients had an abnormal movement of the
vocal folds with a consistency of at least 57.9%. The normal
subjects selected for the study did not have adductory
motion associated with inhalation, exhalation or after
speaking.
Table 3 shows the results obtained from the spirometric
analysis from the experimental (PVFM) and control groups
(normal subjects). The mean FVC% for patients with PVFM
was 91.7 (13.5), while for the normal subjects the FVC%measure was 103.2 (6). Thus, patients with PVFM showed
a statistically significant reduced vital capacity. The FIVC%
was also significantly lower in patients with PVFM with
a mean value of 87.6 (19.9), while for the normal subjects
the FIVC% measure was 100.2 (3.5).
The FIV0.5/FIVC was found to show significant statistical
difference between the two groups. All of the patients with
PVFM presented with abnormal FIV0.5/FIVC ratios, with
a mean of 0.66 (0.15), while the normal group produced
the ratio with a mean of 0.94 (0.03). These results were
statistically significant at the 0.05 level. The measures of
the forced inspiratory flow weren’t statistically different
among groups.
Discussion
This is the first study with a large cohort of subjects with
PVFM who were compared to a normal group using both
endoscopy and spirometry during periods of no exercise.
According to Gimenez and Zafra, the need to use both
spirometry and laryngoscopy will improve our knowledge of
VCD/PVFM since the prevalence of this condition is still not
known.15 In the current study, the patients with PVFM were
found to have adductory motion on inhalation, at times
during exhalation and following speech. Of significance was
the finding of inspiratory motion following a short phrase
suggesting that these patients exhibit a paradoxical motion
with inspiration following speech more consistently than
the other two conditions. The data analyzed in this study
indicated the occurrence of PVFM in adults of both genders.
Uncharacteristic pulmonary function measures were
noted in those patients with PVFM. The finding of abnormal
spirometric measures in patients with adductory motion
observed during flexible endoscopy supports the usage of
Table 2 Inter-judge reliability of the perceptual analysis of the abnormal adduction of the vocal folds of the PVFM group.
Judge 1% Judge 2% Inter-judge reliability
Adduction of the vocal folds after speaking
Presence 100 100 p < 0.001
Consistency 84.2 78.9 p < 0.001
Adduction of the vocal folds during inhalation
Presence 86.8 89.5 p < 0.001
Consistency 76.3 76.3
Adduction of the vocal folds during exhalation
Presence 65.8 76.3 p < 0.001
Consistency 71.1 57.9 p < 0.001
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in the diagnosis of PVFM. Furthermore, the data support the
hypothesis both endoscopic evidence and spirometric
values for FVC%, FIVC % and FIV0.5/FIVC are important
measures to further identify the PVFM population.
Studies investigating the role of spirometry in PVFM
diagnosis support the finding of abnormal pulmonary func-
tion tests in PVFM. Vertigan et al.13 investigated expiratory
versus inspiratory phases of normal subjects and those with
PVFM. Their results showed those people with PVFM to have
normal expiratory measures; however, an atypical attenu-
ation in the inspiration phase was documented.
The current findings corroborate the earlier work of
Vertigan13 as it relates to PVFM. Results of the present
study revealed ratio measures of FIV0.5/FIVC in PVFM to be
significantly lower than that of a group of normal subjects
with endoscopically-documented evidence of no PVFM.
Unlike the normal subjects, the PVFM group showed an
observable truncating of the inspiratory phase, as well as
a clear difference in inspiratory measures. Differing from
findings of Campbell et al,14 the current study suggests that
patients with PVFM most often have normal or near normal
expiratory patterns with abnormal inspiratory patterns.
Nonetheless, the PVFM subjects in the present study had
a reduced FVC compared to the normal group. Additionally,
results of this study, found that forced expiratory versusTable 3 Comparison of inspiratory function measures between
PVFM
Inspiratory function measures Mean
FVC%a 91.7
FIVC%a 87.6
FIV0.5/FIVC
b 0.66
FIF50/FEF50 1.04
FIF50 4.3
FVC%: The percent of forced vital capacity
FIVC%: The percent of forced inspiratory vital capacity
FIV.05: The forced inspiratory volume at .05 s of the inspiratory phase
FIF 50: Forced inspiratory flow at the 50% point of inspiration
FEF 50: Forced expiratory flow at the 50% point of expiration.
a p<0.001.
b p<0.05.inspiratory flow beyond the initiation of inspiration (FIV0.5)
was not significant. This reveals stronger evidence that
spirometric values indicative of inspiratory characteristics
are most crucial in identifying patients with PVFM when
patients present with symptoms of shortness of breath and
cough and a normal expiratory flow-volume loop. Murry
et al.16 compared a group of PVFM patients before and after
combined behavioral and pharmacological treatment with
proton pump inhibitors and described a statistically signif-
icant improvement in FIV0.5/FIVC in 95% of patients.
However, the mean FIV0.5/FIVC following therapy remained
persistently lower than that of the normal control group.
They reported that these abnormal ratios were consistent
with a decrease in inspiratory volume as a result of extra
thoracic obstruction, and not due to increased airways
obstruction as suggested by Rundel.3
Varney et al.17 reported that amitriptyline also offers
successful treatment when combined with psycho-
therapeutic and behavioral treatments. In that study,
confirmation of the diagnosis was by endoscopic evaluation
and spirometry. In that study, there was no control group
for comparison. A surprising finding in the current study was
the identification of the high incidence of adduction of the
vocal folds following speech. While the complaints of
speech difficulties and hoarseness were relatively low in
the PVFM population, the presence of observed irregularnormal and PVFM subjects.
Normal
Standard
Deviation
Mean Standard
Deviation
13.5 103.2 6.0
19.9 100.2 3.5
0.15 0.94 0.03
0.38 1.01 0.29
1.5 5.5 1.16
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or the 38 subjects indicated dysphonia on their intake case
history form. It may be that the symptoms of shortness of
breath and cough mask the issues related to the voice in
patients with PVFM.
Discrepancies have been reported as to which spiro-
metric values are associated with airway obstruction
versus typically healthy adults. Ratios of FEF50%/FIF50%
greater than 1 are often believed to be indicative of
upper airway obstruction or narrowing.11 However, one
study has reported that ratios over 1.6 have been found in
large groups of healthy men.18 This increased percentage
suggests that a wider range of normal values for standard
spirometric measures should be considered. In addition,
Campbell et al14 found that spirometric values can vary
somewhat depending on body mass index (BMI), age,
gender and smoking status. The current groups of
subjects did not represent a wide range of weight or body
mass.
The results of this study found that the expiratory-
inspiratory ratios in the subjects with clinically docu-
mented PVFM obtained via TFL at rest were significantly
different from the normal group. Thus, the use of the
inspiratory phase measures provides an additional indicator
of PVFM from other conditions presenting with cough,
shortness of breath and other vocal fold anomalies. It
should be noted that judges did not see the adductory
motion during the entire examination sequence. In some
cases, as shown in Table 2, the adductory motion was
present but not consistent. Thus, thorough examination
with TFL is important when suspecting PVFM.Conclusion
The present study found that the inspiratory measure of
FIVC%, FVC% and FIV0.5/FIVC were significantly lower in the
PVFM group compared to the normal subjects Flow-volume
curves, specifically inspiratory measures, provide diag-
nostic evidence to support the findings of the TFL exami-
nation. The results of the endoscopic judgments indicate
that paradoxical motion occurs whether breathing through
the nose or mouth in the PVFM subjects, mainly after
speaking and inhalation. The finding of vocal fold closure
following speech in the majority of the PVFM group
warrants further investigation.Conflict of interest statement
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